Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6201–6250 of 34715
On October 15, 2024, Eduardo Iniguez, the Chief Executive Officer of Getaround, Inc. (the “Company”), resigned from his position as Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective as of such date.
Dr. Mendl was appointed to the Board upon designation by Volkswagen Group of America Investments, LLC pursuant to the amended and restated letter agreement entered into with the Company on July 5, 2024, occupying one of the two Board seats designated to representatives of the Volkswagen Group and succeeding Frank Blome who resigned from the Board in July 2024.
On October 21, 2024, the Board of Directors (the “Board”) of Stanley Black & Decker, Inc. (the “Company”) elected John L. Garrison, Jr. as a director of the Company.
On October 23, 2024, Yael Zheng informed the Board of her intent to voluntarily resign from her positions as a director of the Company and member of the Board’s Audit Committee and Compensation Committees, effective as of the date of the 2024 Annual Meeting.
On October 23, 2024, Ms. Xu Ni informed the Board of Directors of her immediate resignation as a director of the Company.
Mr. Ebensberger has also been appointed to our Board of Directors.
the appointment of Mr. Frederic Ohana as a member of the Registrant’s Board effective on October 21, 2024.
the resignation, effective on October 16, 2024, of Mr. James Lasry as a member of the Company’s Board of Directors.
On October 19, 2024, Mark Goodman notified Orgenesis Inc. (the “Company”), of his decision to resign as a director of the Company, effective immediately, for personal reasons.
Effective as of October 21, 2024, the Board of Directors (the “Board”) of Trio Petroleum Corp. (the “Company”) appointed James Blake, as a member of the Board to serve as a Class II Director filling the vacancy created by the previous resignation of Michael L. Peterson.
the Board, upon the recommendation of the Governance and Nominating Committee of the Board, appointed Rhea Goff to serve as a non-independent director of the Company, effective October 23, 2024
James C. Hale notified the Company of his decision not to stand for re-election at the 2025 Annual Meeting.
appointed James (J.D.) Fay to the Board to fill the resulting vacancy.
On October 18, 2024, pursuant to the amended and restated bylaws of Evoke Pharma, Inc. (the “Company”), the Board of Directors of the Company (the “Board”) appointed Benjamin Smeal to serve as a Class II director, effective October 18, 2024, with an initial term expiring at the Company’s 2027 annual meeting of stockholders.
On October 16, 2024, following the recommendation of the nominating and governance committee of AdaptHealth Corp. (the “Company”), the Board of Directors of the Company (the “Board”) appointed Diana L. Nole, age 59, to the Board, effective October 16, 2024.
At the Effective Time, Nicholas Fulco and Charles Mullens, who were the directors of Merger Sub immediately prior to the Effective Time, became the directors of Sharecare.
At the Effective Time, Nicholas Fulco and Charles Mullens, who were the directors of Merger Sub immediately prior to the Effective Time, became the directors of Sharecare.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
Jeff Allred, Jeff Arnold, John Chadwick, Sandro Galea, Ken Goulet, Brent Layton, Veronica Mallett, Alan Mnuchin, Rajeev Ronanki, Jeff Sagansky and Nicole Torraco each resigned from the Board and from any and all committees of the Board on which they served.
On October 22, 2024, the Board of Directors (the “Board”) of Eaton Corporation plc (the “Company”) increased its size from eleven to twelve members and elected Andre Schulten to fill the resulting vacancy, effective immediately.
Dr. Benjamin R. Yerxa, Ph.D., Dr. Jean Bennett, Ph.D., M.D., and Dr. Adrienne Graves, Ph.D., were appointed as members of the Board
Dr. Benjamin R. Yerxa, Ph.D., Dr. Jean Bennett, Ph.D., M.D., and Dr. Adrienne Graves, Ph.D., were appointed as members of the Board
Dr. Jay Pepose resigned from the Board, effective immediately after the time of the filing of the First Merger Certificate of Merger
Dr. Benjamin R. Yerxa, Ph.D., Dr. Jean Bennett, Ph.D., M.D., and Dr. Adrienne Graves, Ph.D., were appointed as members of the Board
the Board appointed Roberto Bellini to serve as a Class I director of the Board
Arvind Kush to serve as a Class III director of the Board
Dr. Paul Grint and Ms. Gisele Dion (the " Resigning Directors ") became effective as of the effectiveness of the appointment of their respective successors.
Amit Munshi and David Canner to serve as Class II directors of the Board
Dr. Paul Grint and Ms. Gisele Dion (the " Resigning Directors ") became effective as of the effectiveness of the appointment of their respective successors.
Amit Munshi and David Canner to serve as Class II directors of the Board
appointed Alison Moore, Ph.D. as (i) a Class III director of the Company, with a term of office expiring at the 2027 annual meeting of stockholders and (ii) a member of the Technical Operations Committee of the Board
On October 21, 2024, Hazem Ben-Gacem submitted his resignation from the board of directors (the “Board”) of Investcorp Europe Acquisition Corp I (the “Company”) to pursue other opportunities, effective upon acceptance and approval by the Board.
On October 18, 2024, David Villarreal, a member of the Board of Directors (the “Board”) of Safe & Green Holdings Corp. (the “Company”), notified the Company of his decision to resign from the Board, effective October 18, 2024.
On October 22, 2024, the Board of Directors (the “Board”) of Kennedy-Wilson Holdings, Inc. (the “Company”) upon the recommendation of the Company’s Nominating Committee, elected Ms. Nadine I. Watt and Mr. Michael Eisner as directors of the Company, effective October 22, 2024.
On October 22, 2024, the Board of Directors (the “Board”) of Kennedy-Wilson Holdings, Inc. (the “Company”) upon the recommendation of the Company’s Nominating Committee, elected Ms. Nadine I. Watt and Mr. Michael Eisner as directors of the Company, effective October 22, 2024.
On October 21, 2024, Mr. James C. Moyer resigned from the Board of Directors (the “Board”) of Monolithic Power Systems, Inc. (the “Company”), and as a result, the Board decreased the total number of its authorized directors from eight to seven.
On October 16, 2024, the Board of Directors of Blue Chip Capital Group, Inc. (the “Company”) accepted the resignation of James Lasry as a member of the Company’s Board of Directors.
Effective October 22, 2024, Bitech Technologies Corp. (the “Registrant”) has received and accepted the resignation of Greg Trimarche from the Registrant’s Board of Directors (the “Board”) and any and all Committees thereof.
Mr. Perezalonso Cifuentes resigned to pursue other professional interests.
On October 21, 2024, the Board of Directors (the “Board”) of GRAIL, Inc. (the “Company”) appointed Sarah Krevans to the Board, effective immediately.
On October 22, 2024, the Board of Directors (the “Board”) of WillScot Holdings Corporation acted to increase the size of the Board from 9 to 10 members and appointed Worthing Jackman to serve as a member of the Board to fill the vacancy created by that increase, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.